Company intelligence / Profile preview

Pelican Life Sciences

Apopka, Florida, United States

Ownership: Private
Development stage: Other

Overview

Pelican Life Sciences was a life sciences platform company established in 2005 by the private equity firm Linden LLC (now Linden Capital Partners). The company was designed to consolidate the fragmented laboratory consumables and diagnostic products market through a strategic "buy-and-build" acquisition strategy. During its operation, Pelican acquired several key entities, including Scientech, Somagen Diagnostics, and Clinical Diagnostics, allowing it to offer a comprehensive range of laboratory equipment, reagents, and diagnostic kits to clinical and research institutions. In February 2008, the company was acquired by Thermo Fisher Scientific, where its operations were integrated into Thermo Fisher's Laboratory Products and Services segment.

Industry: Consumable Medical Devices

Beyond the preview

Go deeper on Pelican Life Sciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pelican Life Sciences.

Explore the full profile